Blood Transfusion Thresholds in Adults

General Transfusion Stopping Thresholds

The American Society of Anesthesiologists recommends a restrictive transfusion strategy, stopping at hemoglobin levels of 7-8 g/dL, as it provides no mortality benefit and increases transfusion-related complications in hemodynamically stable adult patients 1, 2
The restrictive transfusion strategy is strongly recommended for most hospitalized adults based on high-quality evidence showing no increase in mortality, myocardial infarction, stroke, renal failure, or infection compared to liberal strategies targeting 9-10 g/dL 3

For patients with preexisting cardiovascular disease or acute coronary syndrome, stopping transfusion at a hemoglobin level of 8 g/dL is recommended, rather than 7 g/dL, though evidence remains mixed 2, 4
A 2016 meta-analysis showed an increased risk of acute coronary syndrome with restrictive transfusion, but this included heterogeneous populations 2, 4

The assessment of clinical tolerance of anemia, including signs of inadequate oxygen delivery, hemodynamic stability, symptoms, and active ongoing bleeding, is crucial in determining when to stop transfusion 1, 3

Transfusing one unit at a time and reassessing clinical status and hemoglobin after each unit is recommended before deciding whether to continue 3, 5
Each unit of transfusion increases hemoglobin by approximately 1-1.5 g/dL 3

Transfusion is rarely indicated and should be stopped when hemoglobin is >10 g/dL, as this increases risks without providing benefit 6, 3
Increased nosocomial infections, multi-organ failure, transfusion-related acute lung injury, transfusion-associated circulatory overload, and immunosuppression are potential risks associated with transfusion at high hemoglobin levels 3, 6, 7

The 2023 AABB International Guidelines provide high-quality evidence demonstrating that restrictive strategies reduce transfusion exposure by approximately 40% without increasing mortality 1
The TRISS trial demonstrated that restrictive transfusion showed no difference in one-year mortality compared to liberal transfusion in septic shock patients 1

Continuing to transfuse to "normalize" hemoglobin levels above 10 g/dL is not evidence-based and increases complications 6, 3
Ignoring clinical symptoms in favor of arbitrary hemoglobin thresholds can lead to unnecessary transfusions or delayed treatment 2, 3
Using liberal transfusion strategies in sepsis has shown no survival benefit 1, 2
Transfusing multiple units simultaneously without reassessment increases unnecessary exposure to blood products 3, 5